Home/Filings/4/0001871131-24-000002
4//SEC Filing

Kanner Steven 4

Accession 0001871131-24-000002

CIK 0001619856other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 5:06 PM ET

Size

6.9 KB

Accession

0001871131-24-000002

Insider Transaction Report

Form 4
Period: 2024-02-06
Kanner Steven
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-06$2.69/sh+30,577$82,252354,037 total
  • Exercise/Conversion

    Option to purchase Common Stock

    2024-02-0630,57721,623 total
    Exercise: $2.69Exp: 2029-09-30Common Stock (30,577 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates.

Issuer

Caribou Biosciences, Inc.

CIK 0001619856

Entity typeother

Related Parties

1
  • filerCIK 0001871131

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:06 PM ET
Size
6.9 KB